Regent Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Regent Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,685	Closed	-$699K	–	183
2015 Q2	$699K	Hold	5,685	–	–	0.35%	82
2015 Q1	$651K	Hold	5,685	–	–	0.33%	88
2014 Q4	$575K	Buy	5,685 +1,305	+30%	+$127K	0.3%	95
2014 Q3	$399K	Buy	+4,380	New	+$384K	0.2%	122
2014 Q2	–	Sell	-4,710	Closed	-$371K	–	193
2014 Q1	$371K	Buy	+4,710	New	+$392K	0.2%	131

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Regent Investment Management's IBB Position: Q3 2015 in Review

Regent Investment Management sold out of iShares Biotechnology ETF (IBB) in Q3 2015, closing a stake of 5,685 shares — an estimated $699K sold.

Regent Investment Management first reported a position in IBB in Q1 2014 and held it in 5 quarters. The position peaked at $699K in Q2 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

Regent Investment Management reported no remaining iShares Biotechnology ETF position as of Q3 2015 after selling out during the quarter.
Regent Investment Management sold 5,685 iShares Biotechnology ETF shares in Q3 2015, an estimated $699K.
Regent Investment Management first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 5 quarters.
Regent Investment Management's iShares Biotechnology ETF position peaked at $699K in Q2 2015.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on Regent Investment Management's 13F filing for Q3 2015, filed 16 Oct 2015.